| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/01/2005 | EP1534331A2 Membrane associated tumor endothelium markers |
| 06/01/2005 | EP1534290A2 Novel inhibitors of kinases |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534264A2 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 06/01/2005 | EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/01/2005 | EP1534248A1 Lasofoxifene tablet and its coating |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1347760B1 Nmda receptor agonist pharmaceutical compositions |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622994A TGF-beta-specific covalently closed antisense molecule |
| 06/01/2005 | CN1622938A 方法 Method |
| 06/01/2005 | CN1622816A Composition and method for augmenting kidney function |
| 06/01/2005 | CN1622806A Method for the treatment of overactive bladder |
| 06/01/2005 | CN1622803A Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 06/01/2005 | CN1621094A Gene transfer for regulating smooth muscle tone |
| 06/01/2005 | CN1621086A Medicine for treating nephritis |
| 06/01/2005 | CN1621067A Medicine for treating urinary tract infection |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/31/2005 | US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/31/2005 | US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 05/31/2005 | US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/31/2005 | US6900043 Phosphatases which activate map kinase pathways |
| 05/26/2005 | WO2005028438A9 Novel piperidine derivative |
| 05/26/2005 | US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113396 Na+/H++exchanger-3 (NHE-3) inhibitors; antiischemic agents |
| 05/26/2005 | US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic |
| 05/26/2005 | US20050113361 Amide derivatives as NMDA receptor antagonists |
| 05/26/2005 | US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/26/2005 | US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone |
| 05/26/2005 | US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders |
| 05/26/2005 | US20050113284 Drug for regenerating tissue and vessel and method therefor |
| 05/26/2005 | US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/26/2005 | US20050112721 Chimeric peptide immunogens |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112206 Mixture of drug, aminoacrylate polymer and acid |
| 05/26/2005 | US20050112117 Molecules and methods for inhibiting shedding of KIM-1 |
| 05/26/2005 | US20050112114 Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 05/26/2005 | CA2545060A1 Methods of use of thrombin receptor antagonists |
| 05/26/2005 | CA2544747A1 At1-receptor antagonists for treating nephrotic syndrome |
| 05/26/2005 | CA2544503A1 Pharmaceutical composition consisting of a beta-3 adrenoceptor agonist and an alpha agonist |
| 05/26/2005 | CA2544048A1 Pharmaceutical composition for treating stress incontinence and/or mixed incontinence |
| 05/25/2005 | EP1533312A1 Hetero-bicyclic compounds |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532978A1 Remedy for urinary frequency and urinary incontinence |
| 05/25/2005 | EP1532242A2 Methods for preparing purified prostaglandin e synthase |
| 05/25/2005 | EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/25/2005 | EP1532133A1 Nf-:b inhibitors |
| 05/25/2005 | EP1532122A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 05/25/2005 | EP1531867A1 Metastable pharmaceutical compositions |
| 05/25/2005 | EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors |
| 05/25/2005 | EP1531806A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 05/25/2005 | EP1322286B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | EP1282592B1 Use of amines |
| 05/25/2005 | EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist |
| 05/25/2005 | CN1620510A Cytokine protein family |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620461A 2-amino-propanol derivatives |
| 05/25/2005 | CN1620459A 稠合双环嘧啶衍生物 Fused bicyclic pyrimidine derivative |
| 05/25/2005 | CN1620458A 噻吩并嘧啶 Thienopyrimidine |
| 05/25/2005 | CN1620457A Tetracyclic heterocompounds as estrogen receptor modulators |
| 05/25/2005 | CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 05/25/2005 | CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620312A Remedies for chronic kidney diseases |
| 05/25/2005 | CN1620285A Novel microsphere and method for production thereof |
| 05/25/2005 | CN1618435A Oral liquor for promoting-blood circulation and removing blood stasis contg. Radix astragali and ginseng |
| 05/25/2005 | CN1203070C Thrombin receptor antagonists |
| 05/25/2005 | CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/25/2005 | CN1202849C Oral liquid for nephrosis |
| 05/25/2005 | CN1202845C Medicine for treating prostatosis and its prepn |
| 05/25/2005 | CN1202837C Application of sea horse in preparation of medicine and health care food for treating benign prostatauxe |
| 05/25/2005 | CN1202830C Use of Rhizoma dioscoreae nipponicae and its dioscorea saponin treating chronic glomerulus nephritis |
| 05/25/2005 | CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 05/25/2005 | CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack |
| 05/25/2005 | CN1202815C Delayed-action form of administration containing tramadol saccharinate |
| 05/25/2005 | CN1202735C Pet for copmosition |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |